Promoter polymorphisms of tumor necrosis factor-α are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma

International Journal of Cancer

Volumn 110, Issue 5, 2004, Pages 695-700

  Wu, Ming Shiang ^a   Chen, Li Tzong ^b   Shun, Chia Tung ^a   Huang, Shih Pei ^a   Chiu, Han Mo ^a   Wang, Hsiu Po ^a   Lin, Ming Tsang ^a   Cheng, Ann Lii ^a   Lin, Jaw Town ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cytokine polymorphism; Gastric malignancy; Helicobacter pylori; Host susceptibility; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; FEMALE; GASTRIC MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIAL IMMUNITY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROMOTER REGION; STOMACH MUCOSA;

ADENOCARCINOMA; AGED; ALLELES; DNA PRIMERS; FEMALE; GASTRIC MUCOSA; GENE FREQUENCY; GENOTYPE; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-1; LYMPHOID TISSUE; LYMPHOMA; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; STOMACH NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942550580     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20199     Document Type: Article

References (48)

1. Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000;96:410-9.
2. Du MQ, Isaacson PG. Gastric MALT lymphoma: from etiology to treatment. Lancet Oncol 2002;3:97-104.
3. Sepulveda AR, Coelho LGV. Helicobacter pylori and gastric malignancy. Helicobacter 2002;7:37-42.
4. Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinoma. Nat Rev 2002;2:28-37.
5. Bjorkholm B, Falk P, Engstrand L, Nyren O. Helicobacter pylori: resurrection of the cancer link. J Intern Med 2003;253:102-19.
6. Sugimura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, Hunter A, Reeve AE, Sugimura H, Yamaguchi N, Yokota J. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis 1999;20:1127-31.
7. Malaty HM, Engstrand L, Pedersen NL, Graham DY. Helicobacter pylori infection: genetic and environmental influences. Ann Intern Med 1994;120:982-6.
8. Magnusson PKE, Enroth H, Eriksson I, Held M, Nyren D, Engstrand L, Hansson LE, Gyllensten UB. Gastric caner and human leukocyte antigen: distinct DQ and DR alleles are associated with development of gastric cancer and infection by Helicobacter pylori. Cancer Res 2001;61:2684-9.
9. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002;100:249-60.
10. El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
11. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliver C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M. Interleukin 1β and interleukin 1 RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823-9.
12. Figueiredo C, Machado C, Pharoah P, Seruca R, Sousa S, Carvallho R, Capelinha AF, Quint W, Caldas C, van Doan LJ, Carneiro F, Sobrinho-Simoes M. Helicobacter pylori and interleukin genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-7.
13. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Park KH. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001;166:41-6.
14. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukwa N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001;26:696-9.
15. Rollinson S, Levene AP, Mensah FK, Roddam PL, Allan JM, Diss TC, Roman JA, MacLennan K, Dixon MF, Morgan GJ. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 2003;102:1007-11.
16. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.
17. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumor necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
18. Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J. Helicobacter pylori caga gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996;110:1744-52.
19. Ernst PB, Gold BD. The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu Rev Microbiol 2000;54:615-40.
20. Westendsop RG, Langermans JA, Huizinga TW, Elouali AH, Verweiu CL, Boomsma DI, Vandenbrouke JP. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-3.
21. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatowski D. Variation of the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
22. Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, Shimosegawa T, Toyota T. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999;117:1062-8.
23. Fitzgibbon J, Grenzelias D, Matthews J, Lister TA, Gupta RK. Tumor necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Hematol 1999;107:388-91.
24. Daries FE, Rollinson SJ, Rawstron AC, Roman E, Richards S, Drayson M, Child JA, Morgan GJ. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. J Clin Oncol 2000;8:2843-51.
25. Tsukasaki K, Miller CW, Kubota T, Takeuchi S, Fujimoto T, Ikeda S, Tomonaga M, Koeffler P. Tumor necrosis factor polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res 2001;61:3770-4.
26. Kunstmann E, Eppeen C, Elitok E, Harder M, Suerbaum S, Peitz U, Schmiegel W, Epplen JT. Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis 1999;20:1756-61.
27. Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, Lin MT, Wang HP, Lin JT. Tumor necrosis factor-α and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 2002;185:106-9.
28. Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi T, Arinobu Y, Otsuka T, Sawabe T, Harashima S, Nagasawa K, Niho Y. Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese. Arthritis Rheum 2001;44:2819-27.
29. Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M, Kuroda Y, Kawakami H, Uchiyama T. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-α, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum Immunol 2000;61:1262-9.
30. Wu MS, Wu CY, Lin MT, Shun CT, Lin JT. Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int J Cancer 2003;104:617-23.
31. Chen LC, Lin JT, Shyu KY, Jan CM, Chen CL, Chiang IP, Liu SM, Su IJ, Cheng AL. Prospective study of Helicobacter pylori eradication therapy in stage IE high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001;19:4245-51.
32. Wu MS, Shun CT, Wang HP, Sheu JC, Lee WJ, Wang TH, Lin JT. Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 1997;112:1457-65.
33. De Jong D, van der Hulst RW, Pals G, van Dijk WC, van der Ende A, Tytgat GNJ, Taal BG, Boot H. Gastric non-Hodgkin's lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol 1996;106:670-5.
34. + Helicobacter pylori infection in high grade gastric MALT B-cell lymphoma. J Pathol 1998;185:409-12.
35. Eck M, Schmausser B, Hass R, Greiner A, Czub S, Muller-Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997;112:1482-6.
36. Koehler CI, Mues MB, Dienes HP, Kriegsmann J, Schirmacher P, Odenthal M. Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analysis of paraffin wax embedded tissues. Mol Pathol 2003;56:36-42.
37. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001;104:485-501.
38. Yoneda T, Imaizumi K, Maeda M, Yui D, Manabe T, Katayama T, Sato N, Gomi F, Morihara T, Mori Y, Miyoshi K, Hitomi I, et al. Regulatory mechanisms of TRAF2-mediated signal transduction by Bcl10, a MALT lymphoma-associated protein. J Biol Chem 2000;275:11114-20.
39. Zapata JM, Krajewska M, Krojewski S, Kitada S, Welsh K, Monks A, McCloskey N, Gordon J, Kipps TJ, Gascoyne RD, Shabaik A, Reed JC. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J Immunol 2000;165:5084-96.
40. van Heel DN, Udalova IA, De Silva AP, McGoven DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP, Kwiatkowski D. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κb transcription factors. Hum Mol Genet 2002;11:1281-9.
41. Younes A, Aggawall BB. Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders. Cancer 2003;98:458-67.
42. Yen JH, Chen CJ, Tsai WC, Lin CH, Du TT, Wu CC, Liu HW. Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 2001;28:1788-92.
43. Shibata J, Goto H, Arisawa T, Niwa Y, Hayakawa T, Nakayama A, Mori N. Regulation of tumor necrosis factor (TNF) induced apoptosis by soluble TNF receptors in Helicobacter pylori infection. Gut 1999;45:24-31.
44. Tseng LH, Chen PJ, Lin MT, Shau WY, Chuang SM, Martin PJ, Hansen JA. Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1β and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 2001;57:318-24.
45. Furata T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H Sugimurra H. Interleukin-1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002;123:92-105.
46. Meenagh A, Williams F, Ross OA, Patterson C, Gorodezky C, Hammond M, Leheny WA, Middleton D. Frequency of cytokine polymorphisms in populations from Western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 2002;63:1055-61.
47. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5′-flanking region of the human tumor necrosis factor-α gene in Japanese. Tissue Antigens 1998;51:605-12.
48. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer 2003;106:953-60.